Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 2 results out of 2
Data Insights
Rifaximin SSD by Bausch Health for Hepatic Encephalopathy: Likelihood of Approval
Rifaximin SSD is under clinical development by Bausch Health and currently in Phase III for Hepatic Encephalopathy. According to GlobalData,...
Data Insights
Rifaximin SSD by Bausch Health for Sickle Cell Disease: Likelihood of Approval
Rifaximin SSD is under clinical development by Bausch Health and currently in Phase II for Sickle Cell Disease. According to...